SCHEMBL6976489

SCHEMBL6976489

OC[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 3/20 0.64
▸ LGALS1 P09382 2/20 0.64
▸ LGALS9 O00182 1/20 0.64
▸ LGALS8 O00214 1/20 0.64
▸ CA12 O43570 3/20 0.48
▸ CA1 P00915 3/20 0.48
▸ CA2 P00918 3/20 0.48
▸ CA9 Q16790 3/20 0.48
▸ PYGB P11216 6/20 0.47
▸ GAA P10253 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18721346 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL17621600 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL7924751 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL13996793 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL1755358 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL14384932 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL15468366 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL16789213 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL7929801 1.00 LGALS3 (0.64) LGALS3LGALS1LGALS9LGALS8CA12
SCHEMBL24115372 0.97 LGALS1 (0.59) LGALS3LGALS1LGALS9LGALS8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362855-A1 BETA-LACTAM COMPOUNDS, PROCESS FOR REPODUCING THE SAME AND SERUM CHOLESTEROL-LOWERING AGENTS CONTAINING THE SAME Kotobuki Pharmaceutical Co., Ltd. (JP) 2003-11-19 — — EP disclosed
Send feedback